SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-08-002272
Filing Date
2008-03-25
Accepted
2008-03-25 17:27:46
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 CATALYST PHARMACEUTICAL PARTNERS, INC. g12401e10vk.htm 10-K 595063
2 EX-31.1 SECTION 302 CERTIFICATION OF CEO g12401exv31w1.htm EX-31.1 8651
3 EX-31.2 SECTION 302 CERTIFICATION OF CFO g12401exv31w2.htm EX-31.2 8778
4 EX-32.1 SECTION 906 CERTIFICATION OF CEO g12401exv32w1.htm EX-32.1 3195
5 EX-32.2 SECTION 906 CERTIFICATION OF CFO g12401exv32w2.htm EX-32.2 3053
6 GRAPHIC g12401g12401graph.gif GRAPHIC 5258
  Complete submission text file 0000950144-08-002272.txt   627590
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33057 | Film No.: 08710209
SIC: 2834 Pharmaceutical Preparations